Back
ESC Premium Access

Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy.

Session: Poster session 2 - Lipids
Topic: Lipids (Epidemiology and Prevention)
Speaker: Assistant Professor F. Gragnano (Caserta, IT)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Felice Gragnano

The University of Campania Luigi Vanvitelli, Caserta (Italy)
0 follower

14 more presentations in this session

Open-label ODYSSEY APPRISE study: interim data from the first 843 participants

Speaker: Professor B. Cariou (Nantes, FR)

Access
Abstract
Like
Thumbnail

A one-year intervention combining weight loss and exercise increases the proportion of lipoprotein constituted by HDL and HDL particle size

Speaker: Doctor L. Pedersen (Copenhagen, DK)

Access
Abstract
Like
Thumbnail

Discordant low-density lipoprotein particle number versus low-density lipoprotein cholesterol is associated with increased C-reactive protein and poorer outcomes

Speaker: Doctor J. Meeusen (Rochester, US)

Access
Abstract
Like
Thumbnail

The cost-effectiveness of PCSK9 inihibitors in Australia

Speaker: Doctor E. Zomer (Victoria, AU)

Access
Abstract
Like
Thumbnail

Coronary artery calcification is an independent predictor of cardiovascular events in familial hypercholesterolemia

Speaker: Associate Professor R. Santos (Sao Paulo, BR)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 2 - Lipids

Speakers: Assistant Professor F. Gragnano, Professor B. Cariou, Doctor L. Pedersen, Doctor J. Meeusen, Doctor E. Zomer...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources